Skip to main content
OpenTrials
Completed

NCT Number: NCT06338670

Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users

This study aims to investigate the clinical performance of the Osia 3 Sound Processor in comparison to the Osia 2 Sound Processor in adults with mixed or conductive hearing loss or single-sided deafness implanted with an Osia implant. Participants will attend four study visits, where they will complete various hearing assessments using the Osia sound processors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hearing Loss, Mixed Conductive-Sensorineural Ear Diseases Hearing Disorders Hearing Loss Hearing Loss, Conductive Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The HEARing CRC

Melbourne, Victoria, 3053, Australia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Implanted with a Cochlear Osia Implant (OSI100 or OSI200)
  • Conductive or mixed hearing loss in the implanted ear. Bone conduction threshold 4-frequency pure tone average (PTA4; mean of bone conduction thresholds at 0.5, 1, 2 and 4 kHz) ≤ 55 dB HL.

OR Single-Sided Deafness in the implanted ear. Air Conduction threshold 4-frequency pure tone average (PTA4; mean of air conduction thresholds at 0.5, 1, 2 and 3 kHz) ≤ 20 dB HL in the good ear.

  • Aged 18 years or older, at time of consent.
  • Minimum experience of 1 month with the Osia 2 Sound Processor.
  • Fluent speaker in the language used to assess speech perception performance.
  • Willing and able to provide written informed consent.
  • For voluntary visit Aqua+ in water only: Be comfortable with going into a swimming pool and putting head under water.

Exclusion criteria

  • Sensitivity to loud sounds.
  • Ongoing infection at or around the sound processor area.
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
  • Use of ototoxic drugs that could be harmful to the hearing, as judged by the investigator
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
  • Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
  • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation).

Treatment and study plan

Cochlear Osia 3 Sound Processor

Device

Osia 3 Sound Processor including sound processor magnets and Osia 3 Aqua +

Cochlear™ Osia® 2 Sound Processor

Device

Osia® 2 Sound Processor and Osia 2 Aqua +

Primary outcomes

  1. Change (within subject) in speech reception threshold in noise with fixed noise level at 65 dB SPL

    Time frame: During week 48-52

    Speech perception in noise will be measured using the Australian Speech Test in Noise (AuSTIN), which is a test that uses Bamford-Kowal-Bench (BKB)-like target sentences presented in adaptive noise. The AuSTIN corpus comprises 80 lists of 20 sentences each, recorded in female voice. The goal of the adaptive Speech-in-Noise test is to obtain the Speech Reception Threshold in noise.

  2. Change (within subject) in aided thresholds in sound field measured at 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 kHz

    Time frame: During week 48-52

    Aided thresholds in sound field will be measured using warble tones presented from a front speaker positioned at 1 m from the subject following the modified Hughson-Westlake procedure. Frequencies to be tested are 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz.

  3. Change (within subject) in the subjective rating of different aspects of sound when listening to sound clips

    Time frame: During week 48-52

    After listening to different sound clips with Osia 3 and the Osia 2 sound processors, the subjects will rate specific aspects of the sound, e.g., loudness or sound quality, on a Likert scale from 1 to 5 in steps of 1. A rating of 1 is least positive while a rating of 5 is most positive. They will also be asked to explain their sound quality experience in their own words per sound clip.

  4. Change (within subject) in the subjective rating of different aspects of sound during a walk

    Time frame: During week 48-52

    The investigator will hold a conversation with the participant in real-life situations while they wear the Osia 3 sound processor (sound processor only or combined with Osia 3 Aqua+) or Osia 2 sound processor. After the walk, the investigator will ask the participant to rate specific aspects of the sound they experienced on a Likert scale from 1 to 5.

  5. Percentage of participants who preferred Osia 3 over Osia 2 sound processor

    Time frame: During week 48-52

    Participants will be asked which device they prefer after having listened with both devices (Osia 2 and Osia 3) to different sound clips.

Sponsors and collaborators

Lead sponsor

Cochlear

Industry

Collaborators

  • Avania

Registry information

Official study title

A Pre-market, Feasibility, Prospective, Open-label, Within Subject Investigation Evaluating the Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Recipients

Acronym: RECONNECT

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 29, 2024
Registry last updated
Jan 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.